G
Giancarlo Marenzi
Researcher at University of Milan
Publications - 204
Citations - 9769
Giancarlo Marenzi is an academic researcher from University of Milan. The author has contributed to research in topics: Myocardial infarction & Heart failure. The author has an hindex of 47, co-authored 180 publications receiving 8715 citations. Previous affiliations of Giancarlo Marenzi include University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
Circulating microRNAs are new and sensitive biomarkers of myocardial infarction
Yuri D'Alessandra,Paolo Devanna,Federica Limana,Stefania Straino,Anna Di Carlo,Paola Brambilla,Mara Rubino,Maria Cristina Carena,Liana Spazzafumo,Marco De Simone,Barbara Micheli,Paolo Biglioli,Felice Achilli,Fabio Martelli,Stefano Maggiolini,Giancarlo Marenzi,Giulio Pompilio,Maurizio C. Capogrossi +17 more
TL;DR: Acute MI up-regulated miR-1, - 133a, -133b, and -499-5p plasma levels, both in humans and mice, whereas miR -122 and -375 were lower than control only in STEMI patients and in mice with acute hind-limb ischaemia, there was no increase in the plasma level of the above miRNAs.
Journal ArticleDOI
Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction
Giancarlo Marenzi,Gianfranco Lauri,Emilio Assanelli,Jeness Campodonico,Monica De Metrio,Ivana Marana,Marco Grazi,Fabrizio Veglia,Antonio L. Bartorelli +8 more
TL;DR: Assessment of the incidence, clinical predictors, and outcome of contrast-induced nephropathy after primary percutaneous coronary intervention for acute myocardial infarction found that preventive strategies are needed, particularly in high-risk patients.
Journal ArticleDOI
N-Acetylcysteine and Contrast-Induced Nephropathy in Primary Angioplasty
Giancarlo Marenzi,Emilio Assanelli,Ivana Marana,Gianfranco Lauri,Jeness Campodonico,Marco Grazi,Monica De Metrio,Stefano Galli,Franco Fabbiocchi,Piero Montorsi,Fabrizio Veglia,Antonio L. Bartorelli +11 more
TL;DR: Intravenous and oral N-acetylcysteine may prevent contrast-medium–induced nephropathy with a dose-dependent effect in patients treated with primary angioplasty and may improve hospital outcome.
Journal ArticleDOI
Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial
TL;DR: Improved 1 year clinical outcomes in patients with acute myocardial infarction receiving intracoronary administration of bone marrow-derived progenitors cells (BMCs) after successful reperfusion therapy are shown.
Journal ArticleDOI
The Prevention of Radiocontrast-Agent–Induced Nephropathy by Hemofiltration
Giancarlo Marenzi,Ivana Marana,Gianfranco Lauri,Emilio Assanelli,Marco Grazi,Jeness Campodonico,Daniela Trabattoni,Franco Fabbiocchi,Piero Montorsi,Antonio L. Bartorelli +9 more
TL;DR: In patients with chronic renal failure who are undergoing percutaneous coronary interventions, periprocedural hemofiltration given in an ICU setting appears to be effective in preventing the deterioration of renal function due to contrast-agent-induced nephropathy and is associated with improved in-hospital and long-term outcomes.